Experience of a Nationwide implementation of single-tablet second-generation integrase inhibitors-based treatment in Mexico
Second-generation INSTIs are effective and durable in this 2-year follow-up analysis, both for ART initiation and optimization in Mexico's population, offering a valuable strategy for improving ART outcomes.
Authors
- Florentino Badial‐Hernández
- Yanink Caro‐Vega (ORCID: https://orcid.org/0000-0001-9212-1560)
- Alicia Menendez (ORCID: https://orcid.org/0000-0002-9037-617X)
- Alethse De la Torre-Rosas (ORCID: https://orcid.org/0000-0002-3607-7013)
- Santiago Ríos
- Juan Luis Mosqueda-Gómez (ORCID: https://orcid.org/0000-0003-1356-684X)
- Juan Sierra‐Madero (ORCID: https://orcid.org/0000-0002-1177-5843)
Institutions
- Clínica Las Condes (CL)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- Universidad Del Valle De Cuernavaca (MX)
- Universidad Regional Miguel Hidalgo (MX)
Publication Details
- Journal
- IJID Regions
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.ijregi.2025.100645
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00